The European Union Has Announced the Finalized EU GMP Annex 1

The European Union has announced the finalized EU GMP Annex 1 for manufacturing sterile medicinal products. It is creating some reservations for manufacturers who are not certain how these changes may impact their total manufacturing operation and output. In particular, as the August 2023 deadline approaches manufacturers will need to take time to unpack the changes and understand how they will impact their standard operating procedures.

Jennifer Parker, Director of Marketing at Benchmark Products, is advising manufacturers not to wait to consider these new policies. She anticipates the evaluation of SOPs against the guidelines in Annex 1 will require manufacturers to revise and overhaul processes, as well as implement entirely new processes.

Jennifer’s Thoughts:

Although drafts of the new Annex 1 regulations that govern the manufacturers of sterile medicinal products have been circulating for some years now, it still presents a number of challenges when it was actually released in August of this year. Companies will have some barriers when it comes to clients which they will need to meet by the deadline of August next year.

The first one is understanding the complexity of the Annex 1 regulations, being a 50-page document and affecting almost all the areas of production, it will take some time to read, understand, and then evaluate against your own SOPs. And then that’s where I think the biggest challenge is, around evaluating those SOPs against the guidelines. Will you need to rewrite entire operating procedures? Do you need to add new ones where there weren’t any before? And then finally, how are you going to validate your new SOPs? What criteria will you use and the types of products and procedures that you have in place already, will they be sufficient enough to meet the validation criteria?

These are all complex decisions that companies need to make within the deadline. So I really urge manufacturers that are undergoing this process to start early, form a team, and really understand how much work will be involved to get more manufacturing facilities up to compliance.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More